Anaplastic lymphoma kinase (ALK) expression in lung adenocarcinoma - clinicopathologic and morphologic features

被引：0
|
作者：
Jasar, D. [1 ]
Kubelka-Sabit, K. [1 ]
Filipovski, V. [1 ,2 ]
机构：
[1] Clin Hosp Acibadem Sistina, Dept Histopathol & Cytol, Skopje, Macedonia
[2] Univ Goce Delchev, Fac Med, Shtip, Macedonia
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-22-00
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [21] Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma.
    van Gaal, J. C.
    Flucke, U. E.
    Roeffen, M. H. S.
    de Bont, E. S.
    Suurmeijer, A. J.
    van der Graaf, W. T.
    Versleijen-Jonkers, Y. M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Implications of ALK (anaplastic lymphoma kinase) in oncohematology
    Cluzeau, T.
    Pecuchet, N.
    Mounier, N.
    Vignot, S.
    BULLETIN DU CANCER, 2010, 97 (08) : 991 - 996
  • [23] Translocations involving anaplastic lymphoma kinase (ALK)
    Duyster, J
    Bai, RY
    Morris, SW
    ONCOGENE, 2001, 20 (40) : 5623 - 5637
  • [24] Translocations involving anaplastic lymphoma kinase (ALK)
    Justus Duyster
    Ren-Yuan Bai
    Stephan W Morris
    Oncogene, 2001, 20 : 5623 - 5637
  • [25] CrizotinibDevelopment of drug resistance in Anaplastic lymphoma kinase (ALK) fusion adenocarcinoma: case report
    Reactions Weekly, 2017, 1668 (1) : 131 - 131
  • [26] Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer
    Komatsu, Masamichi
    Yasuo, Masanori
    Kobayashi, Nobumitsu
    Tateishi, Kazunari
    Ushiki, Atsuhito
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Matoba, Hisanori
    Honda, Takayuki
    Ichikawa, Kosuke
    INTERNAL MEDICINE, 2015, 54 (16) : 2045 - 2049
  • [27] New Recommendation for the Therapy of anaplastic Lymphoma Kinase (ALK)-mutated Lung Cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    CHIRURG, 2021, 92 (06): : 576 - 576
  • [28] Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
    Hainsworth J.D.
    Anthony Greco F.
    Drugs - Real World Outcomes, 2016, 3 (1) : 115 - 120
  • [29] Prevalence of Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Lung Adenocarcinoma Diagnosed at a Tertiary Care Centre in Sri Lanka
    Kaluarachchi, C.
    Rathnayaka, P.
    Rathnayake, H.
    JOURNAL OF PATHOLOGY, 2021, 255 : S52 - S52
  • [30] Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)
    Ghimire, Bipin
    Pokharel, Ashbita
    Karki, Ujjwal
    Thapa, Shrinjaya
    Chisti, Mohammad Muhsin
    CLINICAL LUNG CANCER, 2023, 24 (03) : e113 - e116
12345